American Society of Nephrology's Kidney Week 2024 | News | Updates | iPharmaCenterNovartis presented new data on Fabhalta, showing a significant reduction in proteinuria that was sustained for up to one year Novartis...
EMA Drug Approvals 2024 | CHMP Positive Opinion | October 2024 | iPharmaCenterAlhemo recommended for European approval as first daily subcutaneous prophylactic treatment for haemophilia A or B patients with...
American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting | 2024 | iPharmaCenterNipocalimab Shows Long-Term Disease Control in Adolescents with Generalized Myasthenia Gravis in Phase 2/3 Trial The first FcRn inhibitor...